InvestorsHub Logo
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: genisi post# 926

Sunday, 06/15/2008 4:43:28 AM

Sunday, June 15, 2008 4:43:28 AM

Post# of 1367
BiolineRX Ltd. (TASE:BLRX) reported that its schizophrenia drug, BL-1020, starts phase IIb as planned. Results are expected on 3Q09.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.